Cargando...
EUROPA: Has Anything New Been Learned With Angiotensin‐Converting Enzyme Inhibitors?
The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) involved 12,218 patients with stable coronary artery disease. Patients in this trial were randomized to the angiotensin‐converting enzyme inhibitor perindopril (8 mg/d) or placebo in additio...
Guardado en:
| Publicado en: | J Clin Hypertens (Greenwich) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Le Jacq Ltd.
2007
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109312/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2005.04555.x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|